LUTETIUM

LUTETIUM was reported 13841 times

LUTETIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHATIC OBSTRUCTION 1 0.0116
1 APPLICATION SITE NODULE 1 0.0073
2 ANAL INFECTION 1 0.0039
3 INJECTION SITE CYST 1 0.0034
4 VULVITIS 1 0.0030
5 SKIN LAXITY 1 0.0023
6 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
7 BILIARY DILATATION 1 0.0007
8 LEUKAEMIA RECURRENT 1 0.0006
9 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
10 APPLICATION SITE DISCOMFORT 1 0.0006
11 BLOOD IRON INCREASED 1 0.0005
12 HYPOREFLEXIA 1 0.0005
13 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
14 APPLICATION SITE HAEMORRHAGE 1 0.0004
15 BONE MARROW DISORDER 1 0.0003
16 VENOUS THROMBOSIS 1 0.0003
17 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
18 GASTROINTESTINAL INFECTION 2 0.0002
19 MALABSORPTION 1 0.0002
20 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
21 PRODUCT SUPPLY ISSUE 1 0.0001
22 GASTROINTESTINAL INFLAMMATION 1 0.0001
23 BLOOD MAGNESIUM DECREASED 1 0.0001
24 LIGAMENT SPRAIN 1 0.0001
25 INJECTION SITE DISCOMFORT 1 0.0001
26 INJECTION SITE NODULE 1 0.0001
27 TOOTH FRACTURE 1 0.0001
28 MALNUTRITION 1 0.0001
29 CYST 1 0.0001
30 MUSCLE ATROPHY 1 0.0001
31 IMMUNE SYSTEM DISORDER 1 0.0001
32 DEVICE RELATED INFECTION 1 0.0001
33 PNEUMOTHORAX 1 0.0001
34 METASTASES TO LIVER 1 0.0001
35 APPLICATION SITE PAIN 1 0.0000
36 PRESYNCOPE 1 0.0000
37 HEPATITIS 1 0.0000
38 GASTRITIS 1 0.0000
39 LIMB INJURY 1 0.0000
40 ASCITES 1 0.0000
41 BLOOD POTASSIUM DECREASED 1 0.0000
42 HEART RATE DECREASED 1 0.0000
43 DYSURIA 1 0.0000
44 INJECTION SITE MASS 1 0.0000
45 LUNG NEOPLASM MALIGNANT 1 0.0000
46 LUNG DISORDER 1 0.0000
47 FLUID RETENTION 1 0.0000
48 INFLAMMATION 1 0.0000
49 BRADYCARDIA 1 0.0000
50 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
51 HAEMATOCHEZIA 1 0.0000
52 OXYGEN SATURATION DECREASED 1 0.0000
53 BONE PAIN 1 0.0000
54 DISEASE PROGRESSION 2 0.0000
55 PLEURAL EFFUSION 1 0.0000
56 SLEEP DISORDER 1 0.0000
57 THERAPY INTERRUPTED 1 0.0000
58 INJECTION SITE SWELLING 1 0.0000
59 ABDOMINAL DISCOMFORT 2 0.0000
60 SKIN EXFOLIATION 1 0.0000
61 SWELLING 1 0.0000
62 ANAEMIA 2 0.0000
63 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
64 ABDOMINAL DISTENSION 1 0.0000
65 CONSTIPATION 2 0.0000
66 INFLUENZA 1 0.0000
67 THROMBOCYTOPENIA 1 0.0000
68 WEIGHT INCREASED 2 0.0000
69 MUSCULAR WEAKNESS 1 0.0000
70 DECREASED APPETITE 2 0.0000
71 ABDOMINAL PAIN 2 0.0000
72 RENAL FAILURE 1 0.0000
73 DRY SKIN 1 0.0000
74 NEUTROPENIA 1 0.0000
75 PRODUCT DOSE OMISSION ISSUE 2 0.0000
76 MYALGIA 1 0.0000
77 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
78 NASOPHARYNGITIS 1 0.0000
79 CHEST PAIN 1 0.0000
80 ALOPECIA 1 0.0000
81 ABDOMINAL PAIN UPPER 1 0.0000
82 INSOMNIA 1 0.0000
83 WEIGHT DECREASED 1 0.0000
84 COUGH 1 0.0000
85 OFF LABEL USE 3 0.0000
86 INJECTION SITE PAIN 1 0.0000
87 DIARRHOEA 2 0.0000
88 FALL 1 0.0000
89 PYREXIA 1 0.0000
90 MALAISE 1 0.0000
91 VOMITING 1 0.0000
92 DIZZINESS 1 0.0000
93 PAIN 1 0.0000
94 HEADACHE 1 0.0000
95 NAUSEA 1 0.0000
96 DEATH 1 0.0000